Background: Whether hospitalized patients benefit from COVID-19 oral antivirals is uncertain. Objective: To examine the real-world effectiveness of mo...Read more

香港大學藥理及藥劑學系的研究發現，新冠疫苗在Omicron變異株流行期間，對接種三針的長者在預防嚴重併發症及減少重症患者數目方面的效果達8成以上。研究還發現，患有多種疾病的市民接種3針疫苗後，死亡率較接種2針減少超過9成。團隊認為，疫苗的抗體保護可能持續6至9個月，定期接種加強針是必要的。...

接种新冠疫苗后其中一个非常罕见副作用是贝尔面瘫，即暂时性一侧面部下垂。香港大学医学院统计去年2月23日至5月4日期间疫苗接种数据，发现接种科兴疫苗或复必泰疫苗后，分别有28宗及16宗贝尔面瘫个案。但专家认为，接种疫苗的效益较风险为高。...

香港大學的一項研究發現，在接種兩劑輝瑞-BioNTech疫苗後，突發性心肌炎的風險增加了10.81倍。接種輝瑞- BioNTech和科興疫苗後的心肌炎粗發病率分別為18.94和5.22，每百萬劑次。風險仍被認為是非常罕見的，但在接種輝瑞- BioNTech疫苗的第二劑後風險更高。...

儘管政府降低了年齡門檻，但香港未滿3歲的幼童仍未能接種COVID-19疫苗。臨床專家正在等待有關科興疫苗適合6個月至2歲幼童接種的官方數據。與此同時，香港大學的一項研究發現，患有慢性病的患者接種疫苗後的不良事件風險與未接種者沒有顯著差異。...

香港大學醫學院對四個不同的高風險群體進行了研究，包括慢性病患者和類風濕性關節炎患者等，發現接種新冠病毒疫苗後出現副作用或異常事件的風險與未接種疫苗者相比並無顯著差異。他們鼓勵高風險群體盡早接種疫苗。...

Background: With accruing case reports on de novo or relapsing glomerular diseases (GD) following different severe acute respiratory syndrome coronavi...Read more

Data regarding protection against mortality and severe complications after Omicron BA.2 infection with CoronaVac and BNT162b2 vaccines remains limited...Read more

Background: Observable symptoms of Bell's palsy following vaccinations arouse concern over the safety profiles of novel coronavirus disease 2019 (COVI...Read more

Importance: COVID-19 has required universities to rapidly develop vaccination policies for students and staff, yet little is known about the preferenc...Read more

Background: Safety after the second dose of the SARS-CoV-2 vaccine remains to be elucidated, especially among individuals reporting adverse events aft...Read more

Prior research using electronic health records for Covid-19 vaccine safety monitoring typically focuses on specific disease groups and excludes indivi...Read more

Background: Contact tracing and intensive testing programs are essential for controlling the spread of COVID-19. However, conventional contact tracing...Read more

Young male BioNTech vaccine recipients have the highest risk of developing heart inflammation after their second Covid-19 jab, with more than 18 cases...Read more

BACKGROUND: This study aims to evaluate waning effectiveness against severe and fatal COVID-19 with two to three doses of CoronaVac/BNT162b2, where da...Read more

IntroductionEvidence on long-term associations between COVID-19 and risks of multi-organ complications and mortality in older population is limited. T...Read more

Extended intervals between the first and second doses of mRNA Covid-19 vaccines may reduce the risk of myocarditis in children and adolescents. Howeve...Read more

香港大學分析了本港兩款COVID-19疫苗的數據，發現接種第二劑科興疫苗後心肌炎的風險是接種前的10.81倍。年輕人和男性的風險也較高。然而，研究團隊仍認為接種疫苗的益處大於風險。...

Background Association between messenger RNA (mRNA) COVID-19 vaccines and myocarditis has aroused public concern over vaccine safety. Objectives Th...Read more